Get the Stockscreener App
0.756
27.12%
0.1613
After Hours:
.71
-0.046
-6.08%
Nexgel Inc stock is traded at $0.756, with a volume of 889.57K.
It is up +27.12% in the last 24 hours and down -9.03% over the past month.
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.
See More
Previous Close:
$0.5947
Open:
$0.61
24h Volume:
889.57K
Relative Volume:
3.47
Market Cap:
$6.41M
Revenue:
$11.42M
Net Income/Loss:
$-2.89M
P/E Ratio:
-1.9843
EPS:
-0.381
Net Cash Flow:
$-1.38M
1W Performance:
+18.57%
1M Performance:
-9.03%
6M Performance:
-70.12%
1Y Performance:
-73.00%
1-Day Range:
$0.5901
$0.78
1-Week Range:
$0.56
$0.78
52-Week Range:
$0.56
$2.9899
Nexgel Inc Stock (NXGL) Company Profile
Name
Nexgel Inc
Sector
Industry
Phone
215 702-8550
Address
2150 CABOT BLVD WEST,, LANGHORNE
Compare NXGL vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NXGL
Nexgel Inc
|
0.756 | 5.04M | 11.42M | -2.89M | -1.38M | -0.381 |
ISRG
Intuitive Surgical Inc
|
468.36 | 165.94B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
155.52 | 44.30B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
80.73 | 38.96B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
47.93 | 38.69B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
228.80 | 33.61B | 5.40B | 1.49B | 1.78B | 10.12 |
Nexgel Inc Stock (NXGL) Latest News
NEXGEL drops prior Celularity financing plan, sets April 23 update - Stock Titan
NEXGEL reschedules shareholder call, revises financing plan - MSN
NXGL Stock: NEXGEL Signs Deal to Triple Revenue and Turn Profitable With Acquisition of Six Commercial-Stage Regenerative Biomaterial Products - Barchart.com
NEXGEL Reschedules Shareholder Call, Revises Financing Plan - MyChesCo
NEXGEL signs agreement to acquire regenerative biomaterial portfolio - MSN
Pharma News: Should you avoid NEXGEL Inc stock right now2026 EndofYear Setup & Verified Swing Trading Watchlists - baoquankhu1.vn
Momentum Shift: Is NEXGEL Inc Equity Warrant benefiting from innovation trends2026 Sector Review & Momentum Based Trading Signals - baoquankhu1.vn
2 High-Flying Stocks with Exciting Potential and 1 We Ignore - Barchart.com
NexGel Inc stock (US65340W1027): Is its hydrogel innovation strong enough to drive U.S. medical grow - AD HOC NEWS
AUDUSD Update: Breaking Higher Following Completion of Corrective Structure - Barchart.com
AI Stocks: Will NEXGEL Inc benefit from rising consumer demandMarket Growth Review & Daily Price Action Insights - baoquankhu1.vn
TEST TEST TEST - Barchart.com
Sectors Review: Is NEXGEL Inc stock a good pick for beginners2026 Setups & Daily Technical Forecast Reports - baoquankhu1.vn
Analyst Calls: Should you avoid NEXGEL Inc stock right now2026 Trade Ideas & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
NexGel Inc (NXGL) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amid Operational ... By GuruFocus - Investing.com Canada
NEXGEL Reschedules Shareholder Update Conference Call to April 15th at 4:30 P.M. ET to Provide Update on Celularity Transaction - Bitget
NEXGEL drops prior financing plan, pushes Celularity update to April 15 - Stock Titan
3 Reasons to Avoid AIT and 1 Stock to Buy Instead - Barchart.com
3 Reasons to Avoid INGR and 1 Stock to Buy Instead - Barchart.com
NexGel Inc stock: Acquisition Deal to Triple Revenue Sparks Investor Interest - AD HOC NEWS
NVR's Quarterly Earnings Preview: What You Need to Know - Barchart
Sentiment Watch: Is NEXGEL Inc attractive for institutional investors2026 Short Interest & Safe Entry Momentum Tips - baoquankhu1.vn
Nexgel earnings missed by $0.09, revenue fell short of estimates - Investing.com UK
Exclusive: NexGel to acquire regenerative biomaterial portfolio from Celularity, expects to triple revenue - MSN
3 Reasons to Sell RMAX and 1 Stock to Buy Instead - Barchart.com
Fed Watch: Is NEXGEL Inc Equity Warrant still a buy after recent gains - baoquankhu1.vn
Shootin' the Bull about "has to" - barchart.com
NXGL SEC FilingsNexgel Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Nexgel Inc reports results for the quarter ended December 31Earnings Summary - TradingView — Track All Markets
Published on: 2026-04-01 05:28:13 - baoquankhu1.vn
NexGel (NXGL) Releases Q4 2025 Earnings: Revenue Down, Losses Narrow, Cash Tight - Quiver Quantitative
NXGL: Revenue up 31.5% to $11.4M, but ongoing losses and liquidity risks persist - TradingView — Track All Markets
Nexgel 2025 10-K: Revenues $11.4M, EPS (0.38) - TradingView — Track All Markets
NexGel (NASDAQ: NXGL) grows 2025 revenue 31% but warns on going concern - Stock Titan
NEXGEL, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
NXGL PE Ratio & Valuation, Is NXGL Overvalued - Intellectia AI
NEXGEL Reschedules 2025 Financial Results Conference Call to April 8th at 4:30 P.M. ET to Provide Shareholders with an Update on Its Previously Announced Transaction with Celularity - MarketScreener
NEXGEL delays earnings call a week to add detail on Celularity deal - stocktitan.net
Stocks in play: Quarterhill Inc. - Barchart.com
Earnings To Watch: Cal-Maine (CALM) Reports Q1 Results Tomorrow - Barchart.com
NEXGEL Reschedules 2025 Financial Results Conference Call to April 8th at 4:30 P.M. ET to Provide Shareholders With an Update on Its Previously Announced Transaction With Celularity - 富途牛牛
Trend Report: Should you avoid NEXGEL Inc stock right nowWeekly Profit Analysis & Reliable Momentum Entry Alerts - baoquankhu1.vn
How does NEXGEL Inc Equity Warrant score in quality rankingsWeekly Loss Report & Consistent Growth Stock Picks - baoquankhu1.vn
The Metals Company: Unlocking a Klondike-Quality Mineral Rush - Barchart
2 Reasons to Watch MCD and 1 to Stay Cautious - Barchart.com
NEXGEL to pay $15 million for Celularity regenerative biomaterial portfolio - MSN
Insider Trends: Is NEXGEL Inc stock technically oversoldWeekly Gains Report & Weekly Market Pulse Updates - baoquankhu1.vn
Johanna Gonzalez Announces TRUE 4G Method - Barchart.com
Published on: 2026-03-28 04:45:25 - baoquankhu1.vn
Nexgel Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
NexGel Inc Stock: Innovative Medical Gels Positioned for Growth in Healthcare and Beauty Markets - AD HOC NEWS
Nexgel Inc Stock (NXGL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Nexgel Inc Stock (NXGL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Levy Adam R. | Chief Executive Officer |
Dec 24 '25 |
Sale |
1.57 |
4,000 |
6,286 |
357,692 |
0.06%
1.84%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):